Thomas Andersen Schmidt

Medicine & Life Sciences

1. Hospitalization 100%
2. Internal Medicine 99%
3. Hospital Emergency Service 67%
4. Hyperkalemia 55%
5. Randomized Controlled Trials 55%
6. Observational Studies 52%
7. Elderly 45%
8. Aortic Valve 44%
9. Potassium 43%
10. Sternotomy 41%
11. Thoracic Surgery 39%
12. Intraosseous Infusions 39%
13. Pragmatic Clinical Trials 36%
14. recombinant FVIIa 31%
15. Factor VIIa 30%
16. Ribosomal RNA 28%
17. Mortality 28%
18. Pulmonary Atelectasis 26%
19. Ribosomal DNA 26%
20. Heart Valves 25%
21. RNA Sequence Analysis 25%
22. sodium-translocating ATPase 24%
23. Random Allocation 24%
24. Starvation 24%
25. Renin-Angiotensin System 23%
26. Atrial Fibrillation 22%
27. Adenosine Triphosphatases 22%
28. DNA Sequence Analysis 22%
29. Cardiology 22%
30. Hydroxymethylglutaryl-CoA Reductase Inhibitors 21%
31. Operative Time 21%
32. Constriction 21%
33. Coronary Artery Bypass 21%
34. Critical Illness 20%
35. Emergencies 20%
36. Length of Stay 20%
37. Ouabain 19%
38. Critical Care 19%
39. Homeostasis 19%
40. Rodentia 18%
41. Quality of Life 18%
42. Coronary Vessels 18%
43. Odds Ratio 18%
44. Cardiovascular Diseases 17%
45. Intensive Care Units 17%
46. Activities of Daily Living 16%
47. Placebos 15%
48. Insulin 15%
49. Safety 15%
50. Bacteria 15%